pembrolizumab,nivolumab,atezolizumab,ipilimumab
bms,merck,roche
['nivolumab', 'pembro', 'kn564', 'rcc,(-irccs),(-srcc),(-urcc)', 'immotion010', 'kidney cancer', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'key,note,564', 'kn-564', 'sarcoma', 'nivo']
great discussion on the adjuvant therapy landscape in rcc #gu23 long term os data awaited and shared decision making is key 
Medical Director of GU Medical Oncology, Assistant Professor @UCSF with focus on #KidneyCancer. Alum of @UChicago. RTs not endorsements